Coherus Oncology, Inc.
US ˙ NasdaqGM ˙ US19249H1032

SecurityCHRS / Coherus Oncology, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership76,629 shares
Latest Disclosed Value $ 108,813
Sei Investments Co ownership in CHRS / Coherus Oncology, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 76,629 shares of Coherus Oncology, Inc. (US:CHRS) valued at $108,813 USD as of December 31, 2025. The entity filed a previous 13F-HR on February 11, 2025 disclosing 0 shares of Coherus Oncology, Inc.. The current value of the position is $120,691 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F COHERUS ONCOLOGY COM 19249H103 76,629 76,629 109 0.0001
2025-02-11 2024-12-31 13F COHERUS BIOSCIENCES COM 19249H103 0 -342,427 -100.00 0 -100.00
2024-11-12 2024-09-30 13F COHERUS BIOSCIENCES COM 19249H103 342,427 -12,965 -3.65 356 -42.02 0.0005
2024-08-13 2024-06-30 13F COHERUS BIOSCIENCES COM 19249H103 355,392 -1,586 -0.44 615 -28.02 0.0009
2024-05-07 2024-03-31 13F COHERUS BIOSCIENCES COM 19249H103 356,978 -8,444 -2.31 853 -29.85 0.0013
2024-02-14 2023-12-31 13F COHERUS BIOSCIENCES COM 19249H103 365,422 -473,695 -56.45 1,217 -61.25 0.0020
2023-11-14 2023-09-30 13F COHERUS BIOSCIENCES COM 19249H103 839,117 -12,548 -1.47 3,138 -13.70 0.0056
2023-08-11 2023-06-30 13F COHERUS BIOSCIENCES COM 19249H103 851,665 115,146 15.63 3,637 -27.81 0.0063
2023-05-12 2023-03-31 13F COHERUS BIOSCIENCES COM 19249H103 736,519 59,001 8.71 5,038 -6.11 0.0094
2023-02-10 2022-12-31 13F COHERUS BIOSCIENCES COM 19249H103 677,518 14,558 2.20 5,366 -15.79 0.0119
2022-11-14 2022-09-30 13F COHERUS BIOSCIENCES COM 19249H103 662,960 873 0.13 6,371 32.90 0.0142
2022-08-15 2022-06-30 13F COHERUS BIOSCIENCES COM 19249H103 662,087 35,993 5.75 4,794 -40.69 0.0104
2022-05-13 2022-03-31 13F COHERUS BIOSCIENCES COM 19249H103 626,094 88,162 16.39 8,083 -5.85 0.0162
2022-02-14 2021-12-31 13F COHERUS BIOSCIENCES COM 19249H103 537,932 193,917 56.37 8,585 55.30 0.0161
2021-11-12 2021-09-30 13F COHERUS BIOSCIENCES COM 19249H103 344,015 -14,972 -4.17 5,528 11.34 0.0116
2021-08-06 2021-06-30 13F COHERUS BIOSCIENCES COM 19249H103 358,987 -562 -0.16 4,965 -5.48 0.0110
2021-05-12 2021-03-31 13F COHERUS BIOSCIENCES COM 19249H103 359,549 45,440 14.47 5,253 -3.77 0.0132
2021-02-08 2020-12-31 13F COHERUS BIOSCIENCES COM 19249H103 314,109 108,329 52.64 5,459 44.65 0.0141
2020-12-04 2020-09-30 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 205,780 96,528 88.35 3,774 93.44 0.0109
2020-11-06 2020-09-30 13F COHERUS BIOSCIENCES COM 19249H103 205,780 96,528 3,774 9,086.9529
2020-08-17 2020-06-30 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 109,252 90,310 476.77 1,951 527.33 0.0061
2020-08-11 2020-06-30 13F COHERUS BIOSCIENCES COM 19249H103 23,457 4,515 422 1,144.6975
2020-05-14 2020-03-31 13F COHERUS BIOSCIENCES COM 19249H103 18,942 -7,516 -28.41 311 -34.80 0.0011
2020-02-06 2019-12-31 13F COHERUS BIOSCIENCES COM 19249H103 26,458 -7,116 -21.19 477 -30.26 0.0014
2019-11-12 2019-09-30 13F COHERUS BIOSCIENCES COM 19249H103 33,574 -12,870 -27.71 684 -33.40 0.0017
2019-08-14 2019-06-30 13F COHERUS BIOSCIENCES COM 19249H103 46,444 46,444 1,027 0.0034
2018-05-11 2018-03-31 13F COHERUS BIOSCIENCES COM 19249H103 0 -38 -100.00 0 0.0000
2018-02-08 2017-12-31 13F COHERUS BIOSCIENCES COM 19249H103 38 0 0.00 0 -100.00
2017-11-06 2017-09-30 13F COHERUS BIOSCIENCES COM 19249H103 38 38 1 0.0000
2016-05-10 2016-03-31 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 0 0 0 0.0000
2016-02-03 2015-12-31 13F COHERUS BIOSCIENCES COM 19249H103 0 -9,773 -100.00 0 -100.00
2015-11-02 2015-09-30 13F/A-1 COHERUS BIOSCIENCES COM 19249H103 9,773 9,773 196 0.0018
2015-10-30 2015-09-30 13F COHERUS BIOSCIENCES COM 19249H103 9,773 196
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.